{
    "title": "Merck scraps Keytruda trial for prostate cancer after dismal interim data",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11675163/Merck-ends-Keytruda-trial-prostate-cancer-patients-dismal-interim-data.html",
    "date": "2023-01-25",
    "keywords": [
        "cancer",
        "inc",
        "keytruda",
        "prostate",
        "therapy",
        "combination",
        "trial",
        "data",
        "survival",
        "disease",
        "drugmaker",
        "drug",
        "jan",
        "wednesday",
        "blockbuster",
        "immunotherapy",
        "studys",
        "analysis",
        "time",
        "patient",
        "deprivation",
        "xtandi",
        "pfizer",
        "body",
        "setback",
        "merck",
        "use",
        "growth",
        "end",
        "exclusivity",
        "country",
        "government",
        "form",
        "rate",
        "chemotherapy",
        "improvement",
        "type",
        "duct",
        "premarket",
        "trading",
        "reporting",
        "raghav",
        "mahobe",
        "mishra",
        "bengaluru",
        "editing",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}